Hepatology

A retrospective study found that radiotherapy provided local control in unresectable extrahepatic bile duct cancer, while cholangitis, liver failure, and tumour bleeding contributed to at least 40% of deaths.

A multicentre study developed and validated a FIT model combining fibrin degradation products, serum iron, and tumour burden score to predict survival in patients with unresectable hepatocellular carcinoma receiving combined therapy.

Around 700 people received free liver health checks during UEG Week 2026 in Barcelona through the Love Your Liver initiative, highlighting the role of accessible screening, early detection and public health awareness in tackling liver disease.

GDF15 may protect against alcohol-associated liver disease by suppressing neutrophil glycolysis, inflammation, and liver injury.

A study of 9,761 adults linked high allostatic load and unhealthy behaviours to increased all-cause and cardiovascular mortality among participants with MASLD.

CT radiomics and tumour heterogeneity predict β-catenin expression in hepatocellular carcinoma.

An AI model combining ctDNA methylation and clinical data achieved an AUC of 0.903 for detecting liver cancer in patients with hepatitis B.

Researchers identified blood protein markers that could differentiate primary biliary cholangitis from MASLD and healthy controls, highlighting the potential of proteomics to support earlier diagnosis and disease monitoring.